Peijia Medical Limited (9996.HK)
HKD 4.82
(6.17%)
HKD 4.82
(6.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -583.48 Million | -376.19 Million | -436.36 Million | -181.1 Million | -102.59 Million | -38.72 Million |
| Net Income | -391.5 Million | -407.8 Million | -574.21 Million | -2.06 Billion | -531.97 Million | -82.87 Million |
| Depreciation & Amortization | 42.8 Million | 33.98 Million | 26.33 Million | 19.08 Million | 13.33 Million | 4.77 Million |
| Deferred income taxes | - | 35.1 Million | 9.88 Million | -22.53 Million | 308.57 Million | 8.6 Million |
| Stock-based compensation | 28.25 Million | 27.94 Million | 30.93 Million | 36.65 Million | 113.75 Million | 28.75 Million |
| Change in working capital | -262.93 Million | -63.05 Million | -40.82 Million | -14.12 Million | -3.81 Million | -2.54 Million |
| Other non-cash items | -39.25 Million | -2.37 Million | 111.51 Million | 1.86 Billion | -2.46 Million | 4.55 Million |
| Investing Cash Flow | -386.29 Million | -463.27 Million | -424.75 Million | -12.48 Million | 31.95 Million | -8.38 Million |
| Investments in PPE | -316.18 Million | -130.41 Million | -69.73 Million | -25.25 Million | -13.52 Million | -8.38 Million |
| Acquisitions | -6 Million | -500 Thousand | 224.1 Million | -11.73 Million | 59.62 Million | - |
| Investment purchases | -64.35 Million | -260.99 Million | -259.61 Million | -677.26 Million | -137.71 Million | - |
| Sales/Maturities of investments | - | - | 35.5 Million | 689 Million | 122.71 Million | - |
| Other Investing Activities | -210.66 Million | -71.86 Million | -355.01 Million | 12.77 Million | 861 Thousand | 1000.00 |
| Financing Cash Flow | 85.1 Million | 117.43 Million | 741.97 Million | 2.34 Billion | 475.73 Million | 104.43 Million |
| Debt repayment | -90.47 Million | -3.36 Million | -3.15 Million | -1.92 Million | -16.62 Million | -4.5 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -5.18 Million | -64.72 Million | -24.74 Million | -19.21 Million | -34.34 Million |
| Common Stock Issuance | 4.05 Million | -3.07 Million | 749.21 Million | 2.35 Billion | - | - |
| Other Financing Activities | -1.95 Million | 140.68 Million | 741.97 Million | 2.34 Billion | 511.57 Million | 143.27 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -44.46 Million | -63.05 Million | -40.82 Million | -14.12 Million | -4.14 Million | -396 Thousand |
| Other working capital | 29.11 Million | -62.32 Million | -22.61 Million | -35.14 Million | 321 Thousand | -2.14 Million |
| Cash at beginning of period | 1.66 Billion | 2.29 Billion | 2.45 Billion | 504.62 Million | 94.76 Million | 35.1 Million |
| Cash at end of period | 795.76 Million | 1.66 Billion | 2.29 Billion | 2.45 Billion | 504.62 Million | 94.76 Million |
| Capital Expenditure | -316.18 Million | -130.41 Million | -69.73 Million | -25.25 Million | -13.52 Million | -8.38 Million |
| Effect of forex changes on cash | 10.77 Million | 95.58 Million | -42.9 Million | -194.99 Million | 4.76 Million | 2.33 Million |
| Net cash flow / Change in cash | -873.89 Million | -626.44 Million | -162.04 Million | 1.95 Billion | 409.86 Million | 59.65 Million |
| Free Cash Flow | -899.67 Million | -506.6 Million | -506.1 Million | -206.35 Million | -116.11 Million | -47.11 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -71.27 Million | -391.5 Million | -180.46 Million | -212.06 Million | -407.8 Million | -315.82 Million |
| Depreciation & Amortization | 25.73 Million | 42.8 Million | 22.23 Million | 19.19 Million | 33.98 Million | 16.25 Million |
| Deferred income taxes | - | - | - | - | 35.1 Million | 50.02 Million |
| Stock-based compensation | 7.35 Million | 28.25 Million | 12 Million | 16.24 Million | 27.94 Million | 13.03 Million |
| Change in working capital | - | -262.93 Million | -15.35 Million | - | -63.05 Million | -125.37 Million |
| Other non-cash items | -3.19 Million | -39.25 Million | 48.41 Million | -293.69 Million | -2.37 Million | 247.4 Million |
| Investing Cash Flow | -56.31 Million | -386.29 Million | -99.88 Million | -286.4 Million | -463.27 Million | -152.82 Million |
| Investments in PPE | -59.72 Million | -316.18 Million | -89.8 Million | -85.82 Million | -130.41 Million | -79.79 Million |
| Acquisitions | - | -6 Million | - | - | -500 Thousand | - |
| Investment purchases | - | -64.35 Million | - | - | -260.99 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3.41 Million | -210.66 Million | -10.08 Million | -200.58 Million | -71.86 Million | -73.03 Million |
| Financing Cash Flow | -1.67 Million | 85.1 Million | 29.37 Million | 55.73 Million | 117.43 Million | 57.11 Million |
| Debt repayment | -29.23 Million | -90.47 Million | - | -55.63 Million | -3.36 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -26.69 Million | - | - | - | -5.18 Million | -2.08 Million |
| Common Stock Issuance | - | 4.05 Million | - | - | -3.07 Million | - |
| Other Financing Activities | -4.22 Million | -1.95 Million | 29.37 Million | 101 Thousand | 140.68 Million | 59.2 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -44.46 Million | -44.46 Million | - | -63.05 Million | -63.05 Million |
| Other working capital | - | 29.11 Million | 29.11 Million | - | -62.32 Million | -62.32 Million |
| Cash at beginning of period | 795.76 Million | 1.66 Billion | 992.62 Million | 1.66 Billion | 2.29 Billion | 1.88 Billion |
| Cash at end of period | 701.32 Million | 795.76 Million | 992.62 Million | 992.62 Million | 1.66 Billion | 1.66 Billion |
| Capital Expenditure | -59.72 Million | -316.18 Million | -89.8 Million | -85.82 Million | -130.41 Million | -79.79 Million |
| Effect of forex changes on cash | 4.93 Million | 10.77 Million | -13.18 Million | 23.95 Million | 95.58 Million | 42 Million |
| Net cash flow / Change in cash | -94.44 Million | -873.89 Million | - | -677.03 Million | -626.44 Million | -218.22 Million |
| Free Cash Flow | -101.11 Million | -899.67 Million | -202.96 Million | -556.14 Million | -506.6 Million | -244.3 Million |
TCLHF
UHRN
EVOTF
USAS
1683
BOCH